Von Willebrand Disease clinical trials at UCSF
1 research study open to eligible people
Von Willebrand disease affects blood clotting and can cause abnormal bleeding. UCSF is running trials to track the disease over time and develop improved treatments. This research focuses on gathering detailed data about various blood disorders to enhance patient care.
Showing trials for
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
open to all eligible people
In parallel with the growth of American Thrombosis and Hemostasis Network's (ATHN) clinical studies, the number of new therapies for all congenital and acquired hematologic conditions, not just those for bleeding and clotting disorders, is…
Oakland, California and other locations
Our lead scientists for Von Willebrand Disease research studies include Alison Matsunaga, MD.
Last updated: